과제정보
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (2019R1C1C1009875).
참고문헌
- Perez-Jacoiste Asin MA, Fernandez-Ruiz M, Lopez-Medrano F, Lumbreras C, Tejido A, San Juan R, et al. Bacillus CalmetteGuerin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature. Medicine (Baltimore) 2014;93:236-54. https://doi.org/10.1097/MD.0000000000000119
- Mendes P, Robles PG, Mathur S. Statin-induced rhabdomyolysis: a comprehensive review of case reports. Physiother Can 2014;66:124-32. https://doi.org/10.3138/ptc.2012-65
- Akimoto H, Negishi A, Oshima S, Okita M, Numajiri S, Inoue N, et al. Onset timing of statin-induced musculoskeletal adverse events and concomitant drug-associated shift in onset timing of MAEs. Pharmacol Res Perspect 2018;6:e00439.
- Armstrong RW. Complications after intravesical instillation of bacillus Calmette-Guerin: rhabdomyolysis and metastatic infection. J Urol 1991;145:1264-6. https://doi.org/10.1016/S0022-5347(17)38596-8
- Peyriere H, Klouche K, Beraud JJ, Blayac JP, Hillaire-Buys D. Fatal systemic reaction after multiple doses of intravesical bacillus Calmette-Guerin for polyposis. Ann Pharmacother 2000; 34:1279-82. https://doi.org/10.1345/aph.19329
- Dalakas MC. Toxic and drug-induced myopathies. J Neurol Neurosurg Psychiatry 2009;80:832-8. https://doi.org/10.1136/jnnp.2008.168294
- Valiyil R, Christopher-Stine L. Drug-related myopathies of which the clinician should be aware. Curr Rheumatol Rep 2010;12:213-20. https://doi.org/10.1007/s11926-010-0104-3
- Lyons D, Miller I, Jeffers A. Systemic hypersensitivity reaction to intravesical BCG. Scott Med J 1994;39:49-50. https://doi.org/10.1177/003693309403900205